Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland 21287-0910, USA.
Thyroid. 2010 Jul;20(7):771-6. doi: 10.1089/thy.2010.1645.
Personalizing treatment for papillary thyroid cancer (PTC) requires a multidisciplinary approach. The surgical management of PTC has long been based on retrospective studies focusing on endpoints that are of debatable significance. There is considerable debate in the literature regarding the optimal initial treatment for PTC. Many of these issues are discussed in this review. These debates have hindered the development of a tailored treatment strategy.
The ability to optimally personalize a surgical plan for the treatment of PTC is ultimately dependent on an understanding of the biological behavior of that individual patient's tumor. We are at the genesis of an age where molecular biology advances endeavor to profile a patient's tumor behavior. This review summarizes current strategies for managing PTC, where we are with personalizing surgery for these patients, and where we hope to go. Thyroid surgery is one of the newest fields for the application of minimally invasive techniques and can now be accomplished endoscopically or with robotic assistance in many patients who therefore may benefit from these alternative approaches.
When treating a patient with PTC, it seems prudent to weigh the many factors discussed in this review to individualize the most optimal surgical plan.
为甲状腺乳头癌(PTC)制定个性化治疗方案需要采取多学科方法。PTC 的手术治疗长期以来一直基于以有争议意义的终点为重点的回顾性研究。关于 PTC 的初始最佳治疗方法,文献中有很多争议。本综述讨论了其中的许多问题。这些争论阻碍了定制治疗策略的发展。
优化 PTC 手术计划的能力最终取决于对个体患者肿瘤生物学行为的理解。我们正处于一个分子生物学进展努力描述患者肿瘤行为的时代的起点。本综述总结了目前管理 PTC 的策略,包括我们在为这些患者进行手术个性化方面的进展,以及我们希望达到的目标。甲状腺手术是微创技术应用的最新领域之一,现在许多患者可以通过内窥镜或机器人辅助进行手术,因此这些替代方法可能会使他们受益。
在治疗 PTC 患者时,权衡本综述中讨论的许多因素,制定最优化的手术方案似乎是明智的。